selected publications

• article

  • Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial.  Journal of Rheumatology.  41:1077-1087. 2014-01-01
  • Abatacept in subjects who switch from intravenous to subcutaneous therapy: Results from the phase IIIb ATTUNE study.  Annals of the Rheumatic Diseases.  71:857-861. 2012-01-01
  • Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-Year results from the AIM trial.  Annals of the Rheumatic Diseases.  70:1826-1830. 2011-01-01
  • Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate.  Arthritis and Rheumatism.  58:953-963. 2008-01-01
  • Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: A randomized trial.  Annals of Internal Medicine.  144:865-876. 2006-01-01